Orion Oyj is a leading pharmaceutical company based in Finland, with a strong focus on developing and marketing pharmaceuticals for central nervous system disorders, oncology, and respiratory diseases. With a medium ESG score of 20.8, Orion operates globally, serving a wide range of customers including specialists, veterinarians, pharmacies, hospitals, and laboratories. In addition to its presence in Finland, Orion also has operations in other European countries, North America, and beyond.